India, Sept. 18 -- Shares of XORTX Therapeutics Inc. (XRTX) are gaining around 12 percent on Friday morning after the company announced its plans to submit an Investigational New Drug application to the U.S. FDA in the fourth quarter of 2026.
The company's shares are currently trading at $1.8997 on the Nasdaq, up 12.41 percent. The stock opened at $1.99 and has climbed as high as $2.65 so far in today's session. Over the past year, it has traded in a range of $1.59 to $7.05.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....